(Sharecast News) - GENinCode warned on revenues on Tuesday, sending shares in the AIM-listed predictive genetics specialist sliding.
The firm, a specialist in preventing cardiovascular disease and the risk of ovarian cancer, said that while it still expected "good" year-on-year sales growth, revenues were now likely to come in around £3.3m,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE